<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Genital Ulcers</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->5/4/2012</div></div><div class="card__content"><h1 id="genital-ulcers">Genital Ulcers</h1>
<ul>
<li>Leading causes in the US: HSV types 1 and 2 (most common) &gt; syphilis &gt; chancroid</li>
<li>Note: 10% of chancroid are coinfected with syphilis or HSV</li>
</ul>
<h2 id="differential-diagnosis-of-genital-ulcers">Differential diagnosis of genital ulcers</h2>
<table>
<thead>
<tr>
<th><strong>Infectious (more common)</strong></th>
<th><strong>Non-infectious (less common)</strong></th>
</tr>
</thead>
<tbody><tr>
<td>Genital herpes simple virus (HSV)</td>
<td>Behcet syndrome</td>
</tr>
<tr>
<td>Syphilis</td>
<td>Fixed drug eruption</td>
</tr>
<tr>
<td>Chancroid</td>
<td>Psoriasis</td>
</tr>
<tr>
<td>Lymphogranuloma venereum</td>
<td>Sexual trauma</td>
</tr>
<tr>
<td>Granuloma inguinale (donovanosis)</td>
<td>Wegener granulomatosis</td>
</tr>
<tr>
<td>Fungal infection (eg. candida)</td>
<td></td>
</tr>
<tr>
<td>Secondary bacterial infection</td>
<td></td>
</tr>
</tbody></table>
<p><a href="http://www.ncsddc.org/publications">National Coalition of STD Director Fact Sheets</a>
From “The Practitioner’s Handbook for the Management of STDs” (4th ed, 2007):</p>
<table>
  <tr>
    <th></th>
    <th>Primary HSV</th>
    <th>Recurrent HSV</th>
    <th>Syphilis</th>
    <th>Chancroid</th>
    <th>LGV</th>
  </tr>
  <tr>
    <td><b>Primary lesion</b></td>
    <td>Vesicle, papule,ulcers, typically bilateral</td>
    <td>Grouped vesicles, papules, ulcers, typically unilateral  </td>
    <td>Ulcer, papule</td>
    <td>Ulcer, papule</td>
    <td>Papule, pustule, ulcer</td>
  </tr>
  <tr>
    <td><b>Border</b></td>
    <td>Erythematous,"punched out"  </td>
    <td>Erythematous,"punched out"</td>
    <td>Sharply demarcated </td>
    <td>Violaceous, undermined</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td><b>Depth</b></td>
    <td>Superficial</td>
    <td>Superficial</td>
    <td>Superficial</td>
    <td>Excavated</td>
    <td>Superficial</td>
  </tr>
  <tr>
    <td><b>Base</b></td>
    <td>Red and smooth</td>
    <td>Red and smooth</td>
    <td>Red and smooth</td>
    <td>Yellow to gray exudate</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td><b>Secretion</b></td>
    <td>Serous</td>
    <td>Serous</td>
    <td>Serous</td>
    <td>Purulent to hemorrhagic</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td><b>Number of Lesions</b></td>
    <td>Bilateral, multiple, extensive lesion may coalesce</td>
    <td>Usually unilateral; labia, penis, scrotum, buttocks, perianal</td>
    <td>Vulva, penis, anal perianal, oral</td>
    <td>Penis, vulva</td>
    <td>Urethra, cervix, rectum</td>
  </tr>
  <tr>
    <td><b>Induration</b></td>
    <td>None</td>
    <td>None</td>
    <td>Firm</td>
    <td>Rare, usually soft</td>
    <td>None</td>
  </tr>
  <tr>
    <td><b>Pain</b></td>
    <td>Common</td>
    <td>Common, less severe</td>
    <td>Rare</td>
    <td>Often</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td><b>Itching</b></td>
    <td>Common</td>
    <td>Common</td>
    <td>Rare</td>
    <td>Rare</td>
    <td>Rare</td>
  </tr>
  <tr>
    <td><b>Lymph Nodes</b></td>
    <td>Tender, firm, bilateral inguinal adenopathy</td>
    <td>Lymphadenopathy, uncommon, unilateral</td>
    <td>Nontender, firm, enlarged</td>
    <td>Tender, enlarged, may suppurate</td>
    <td>Inguinal and femoral lymphadenopathy: tender, may suppurate</td>
  </tr>
  <tr>
    <td><b>Incubation Period</b></td>
    <td>2-14 days</td>
    <td>Recurrence within 6-9 months of primary infection </td>
    <td>10-90 days</td>
    <td>1-14 days</td>
    <td>3-21 days</td>
  </tr>
  <tr>
    <td><b>Time Course</b></td>
    <td>21 days</td>
    <td>7-10 days</td>
    <td>2-3 weeks</td>
    <td>2-3 weeks</td>
    <td>1-2 weeks</td>
  </tr>
  <tr>
    <td><b>Diagnostic Test</b></td>
    <td>Viral culture</td>
    <td>Viral culture is most sensitive, especially once vesicles rupture and ulcerate. If lesions are granulating, HSV cultures may be negative and HSV serology is useful to confirm etiology.</td>
    <td>Darkfield microscopy, FTA-ABS, VDRL, RPR and DFA-TP</td>
    <td>Culture of <i>Haemophilus ducreyi</i>; Gram stain of pus aspirate from lymph node</td>
    <td>Isolation of <i>Chlamydia trachomatis</i> from urethra, cervix, rectum or lymph node aspirate; complement fixation serology &ge; 1/64</td>
  </tr>
</table>

<h2 id="references">References</h2>
<ul>
<li>Roett MA, Mayor MT, Uduhiri KA. Diagnosis and management of genital ulcers. Am Fam Physician. 2012 Feb 1;85(3):254-62. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=22335265">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"genital-ulcers","title":"Genital Ulcers","authors":["Michelle Lin, MD"],"categories":[{"slug":"infectious-disease","name":"Infectious Disease"},{"slug":"genitourinary","name":"Genitourinary"}],"created":"2012/05/04","updated":null,"body":"\n# Genital Ulcers\n\n- Leading causes in the US: HSV types 1 and 2 (most common) \u003e syphilis \u003e chancroid\n- Note: 10% of chancroid are coinfected with syphilis or HSV\n\n## Differential diagnosis of genital ulcers\n\n| **Infectious (more common)**      | **Non-infectious (less common)** |\n| --------------------------------- | -------------------------------- |\n| Genital herpes simple virus (HSV) | Behcet syndrome                  |\n| Syphilis                          | Fixed drug eruption              |\n| Chancroid                         | Psoriasis                        |\n| Lymphogranuloma venereum          | Sexual trauma                    |\n| Granuloma inguinale (donovanosis) | Wegener granulomatosis           |\n| Fungal infection (eg. candida)    |                                  |\n| Secondary bacterial infection     |                                  |\n\n[National Coalition of STD Director Fact Sheets](http://www.ncsddc.org/publications)\nFrom “The Practitioner’s Handbook for the Management of STDs” (4th ed, 2007):\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003e\u003c/th\u003e\n    \u003cth\u003ePrimary HSV\u003c/th\u003e\n    \u003cth\u003eRecurrent HSV\u003c/th\u003e\n    \u003cth\u003eSyphilis\u003c/th\u003e\n    \u003cth\u003eChancroid\u003c/th\u003e\n    \u003cth\u003eLGV\u003c/th\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003ePrimary lesion\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eVesicle, papule,ulcers, typically bilateral\u003c/td\u003e\n    \u003ctd\u003eGrouped vesicles, papules, ulcers, typically unilateral  \u003c/td\u003e\n    \u003ctd\u003eUlcer, papule\u003c/td\u003e\n    \u003ctd\u003eUlcer, papule\u003c/td\u003e\n    \u003ctd\u003ePapule, pustule, ulcer\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eBorder\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eErythematous,\"punched out\"  \u003c/td\u003e\n    \u003ctd\u003eErythematous,\"punched out\"\u003c/td\u003e\n    \u003ctd\u003eSharply demarcated \u003c/td\u003e\n    \u003ctd\u003eViolaceous, undermined\u003c/td\u003e\n    \u003ctd\u003eVariable\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eDepth\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eSuperficial\u003c/td\u003e\n    \u003ctd\u003eSuperficial\u003c/td\u003e\n    \u003ctd\u003eSuperficial\u003c/td\u003e\n    \u003ctd\u003eExcavated\u003c/td\u003e\n    \u003ctd\u003eSuperficial\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eBase\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eRed and smooth\u003c/td\u003e\n    \u003ctd\u003eRed and smooth\u003c/td\u003e\n    \u003ctd\u003eRed and smooth\u003c/td\u003e\n    \u003ctd\u003eYellow to gray exudate\u003c/td\u003e\n    \u003ctd\u003eVariable\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eSecretion\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eSerous\u003c/td\u003e\n    \u003ctd\u003eSerous\u003c/td\u003e\n    \u003ctd\u003eSerous\u003c/td\u003e\n    \u003ctd\u003ePurulent to hemorrhagic\u003c/td\u003e\n    \u003ctd\u003eVariable\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eNumber of Lesions\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eBilateral, multiple, extensive lesion may coalesce\u003c/td\u003e\n    \u003ctd\u003eUsually unilateral; labia, penis, scrotum, buttocks, perianal\u003c/td\u003e\n    \u003ctd\u003eVulva, penis, anal perianal, oral\u003c/td\u003e\n    \u003ctd\u003ePenis, vulva\u003c/td\u003e\n    \u003ctd\u003eUrethra, cervix, rectum\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eInduration\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eNone\u003c/td\u003e\n    \u003ctd\u003eNone\u003c/td\u003e\n    \u003ctd\u003eFirm\u003c/td\u003e\n    \u003ctd\u003eRare, usually soft\u003c/td\u003e\n    \u003ctd\u003eNone\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003ePain\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eCommon\u003c/td\u003e\n    \u003ctd\u003eCommon, less severe\u003c/td\u003e\n    \u003ctd\u003eRare\u003c/td\u003e\n    \u003ctd\u003eOften\u003c/td\u003e\n    \u003ctd\u003eVariable\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eItching\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eCommon\u003c/td\u003e\n    \u003ctd\u003eCommon\u003c/td\u003e\n    \u003ctd\u003eRare\u003c/td\u003e\n    \u003ctd\u003eRare\u003c/td\u003e\n    \u003ctd\u003eRare\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eLymph Nodes\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eTender, firm, bilateral inguinal adenopathy\u003c/td\u003e\n    \u003ctd\u003eLymphadenopathy, uncommon, unilateral\u003c/td\u003e\n    \u003ctd\u003eNontender, firm, enlarged\u003c/td\u003e\n    \u003ctd\u003eTender, enlarged, may suppurate\u003c/td\u003e\n    \u003ctd\u003eInguinal and femoral lymphadenopathy: tender, may suppurate\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eIncubation Period\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003e2-14 days\u003c/td\u003e\n    \u003ctd\u003eRecurrence within 6-9 months of primary infection \u003c/td\u003e\n    \u003ctd\u003e10-90 days\u003c/td\u003e\n    \u003ctd\u003e1-14 days\u003c/td\u003e\n    \u003ctd\u003e3-21 days\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eTime Course\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003e21 days\u003c/td\u003e\n    \u003ctd\u003e7-10 days\u003c/td\u003e\n    \u003ctd\u003e2-3 weeks\u003c/td\u003e\n    \u003ctd\u003e2-3 weeks\u003c/td\u003e\n    \u003ctd\u003e1-2 weeks\u003c/td\u003e\n  \u003c/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cb\u003eDiagnostic Test\u003c/b\u003e\u003c/td\u003e\n    \u003ctd\u003eViral culture\u003c/td\u003e\n    \u003ctd\u003eViral culture is most sensitive, especially once vesicles rupture and ulcerate. If lesions are granulating, HSV cultures may be negative and HSV serology is useful to confirm etiology.\u003c/td\u003e\n    \u003ctd\u003eDarkfield microscopy, FTA-ABS, VDRL, RPR and DFA-TP\u003c/td\u003e\n    \u003ctd\u003eCulture of \u003ci\u003eHaemophilus ducreyi\u003c/i\u003e; Gram stain of pus aspirate from lymph node\u003c/td\u003e\n    \u003ctd\u003eIsolation of \u003ci\u003eChlamydia trachomatis\u003c/i\u003e from urethra, cervix, rectum or lymph node aspirate; complement fixation serology \u0026ge; 1/64\u003c/td\u003e\n  \u003c/tr\u003e\n\u003c/table\u003e\n\n## References\n\n- Roett MA, Mayor MT, Uduhiri KA. Diagnosis and management of genital ulcers. Am Fam Physician. 2012 Feb 1;85(3):254-62. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=22335265)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"genital-ulcers"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>